Xenetic Biosciences, Inc. (XBIO)

2.27 -0.17 (-6.97%) USD  |  NASDAQ  |  Dec 15, 16:00
2.27 0.00 (0.00%) After-Hours: 19:02
More

Xenetic Biosciences Research and Development Expense (TTM): 2.630M for Sept. 30, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for XBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Iovance Biotherapeutics, Inc. 303.64M
Travere Therapeutics, Inc. 210.21M
KalVista Pharmaceuticals, Inc. 55.64M
BeyondSpring, Inc. --
Solid Biosciences, Inc. 132.96M